AGT and Myocardial fibrosis: Indeed, miRNA-26a–deficient mice have evidence of myocardial fibrosis, whereas the overexpression of miRNA-26a inhibited myocardial fibrosis in vivo and angiotensin II-induced fibrogenesis in cardiac fibroblasts [26].